Accelerate New York Seed Fund

Accelerate New York Seed Fund is a venture capital firm dedicated to fostering early-stage science and technology ventures in Downstate New York. The firm collaborates with Empire State Development to provide critical seed and pre-seed funding to emerging technology companies. Eligible businesses are recently formed, pre-revenue, and have less than $500,000 in invested capital, with principal places of business in New York City, Long Island, and the Mid-Hudson Valley.

The fund focuses on sectors such as technology, healthcare, biotechnology, e-commerce, and financial services. It primarily invests in seed, early-stage, and Series A rounds, aiming to support the growth of innovative startups in the region. The firm has a history of investing in companies like Epivax Oncology and PainQx, contributing to the development of diverse industries.

By partnering with local research institutions and the business community, Accelerate New York Seed Fund plays a pivotal role in commercializing research and creating an entrepreneurial ecosystem in Downstate New York. Its strategic investments aim to drive innovation, job creation, and economic growth in the region, aligning with the state's objectives to support high-growth entrepreneurship and technological advancement.